BROOKDALE SENIOR LIVING - BKD 7 11/15/25 (BKDT) Stock Fundamental Analysis
NYSE:BKDT - New York Stock Exchange, Inc. - US1124633025 - Currency: USD
Overall BKDT gets a fundamental rating of 2 out of 10. We evaluated BKDT against 109 industry peers in the Health Care Providers & Services industry. BKDT may be in some trouble as it scores bad on both profitability and health. BKDT has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
BKDT had negative earnings in the past year.
BKDT had a positive operating cash flow in the past year.
BKDT had negative earnings in 4 of the past 5 years.
BKDT had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
BKDT has a Return On Assets of -3.52%. This is comparable to the rest of the industry: BKDT outperforms 42.59% of its industry peers.
BKDT has a worse Return On Equity (-71.42%) than 74.07% of its industry peers.
BKDT has a Return On Invested Capital of 0.86%. This is in the lower half of the industry: BKDT underperforms 60.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.52% | ||
| ROE | -71.42% | ||
| ROIC | 0.86% |
ROA(3y)-2.99%
ROA(5y)-2.3%
ROE(3y)-33.99%
ROE(5y)-26.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BKDT has a Operating Margin (1.87%) which is in line with its industry peers.
In the last couple of years the Operating Margin of BKDT has declined.
The Gross Margin of BKDT (25.68%) is comparable to the rest of the industry.
BKDT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.87% | ||
| PM (TTM) | N/A | ||
| GM | 25.68% |
OM growth 3Y53.94%
OM growth 5Y-9.99%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y0.99%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BKDT is destroying value.
Compared to 1 year ago, BKDT has more shares outstanding
The number of shares outstanding for BKDT has been reduced compared to 5 years ago.
The debt/assets ratio for BKDT has remained at the same level compared to a year ago.
2.2 Solvency
BKDT has an Altman-Z score of 1.06. This is a bad value and indicates that BKDT is not financially healthy and even has some risk of bankruptcy.
BKDT has a Altman-Z score of 1.06. This is in the lower half of the industry: BKDT underperforms 65.74% of its industry peers.
A Debt/Equity ratio of 14.54 is on the high side and indicates that BKDT has dependencies on debt financing.
BKDT's Debt to Equity ratio of 14.54 is on the low side compared to the rest of the industry. BKDT is outperformed by 87.04% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 14.54 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.06 |
ROIC/WACC0.1
WACC8.16%
2.3 Liquidity
A Current Ratio of 0.81 indicates that BKDT may have some problems paying its short term obligations.
BKDT has a Current ratio of 0.81. This is amonst the worse of the industry: BKDT underperforms 83.33% of its industry peers.
A Quick Ratio of 0.81 indicates that BKDT may have some problems paying its short term obligations.
The Quick ratio of BKDT (0.81) is worse than 75.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.81 | ||
| Quick Ratio | 0.81 |
3. Growth
3.1 Past
BKDT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -61.40%.
Looking at the last year, BKDT shows a small growth in Revenue. The Revenue has grown by 4.63% in the last year.
The Revenue has been decreasing by -7.82% on average over the past years.
EPS 1Y (TTM)-61.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)4.63%
Revenue growth 3Y-5.2%
Revenue growth 5Y-7.82%
Sales Q2Q%3.55%
3.2 Future
Based on estimates for the next years, BKDT will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.21% on average per year.
Based on estimates for the next years, BKDT will show a small growth in Revenue. The Revenue will grow by 0.41% on average per year.
EPS Next Y11.63%
EPS Next 2Y11.29%
EPS Next 3Y9.21%
EPS Next 5YN/A
Revenue Next Year3.68%
Revenue Next 2Y3.96%
Revenue Next 3Y0.41%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for BKDT. In the last year negative earnings were reported.
Also next year BKDT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
BKDT's Enterprise Value to EBITDA ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 42.37 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.29%
EPS Next 3Y9.21%
5. Dividend
5.1 Amount
BKDT has a Yearly Dividend Yield of 5.03%, which is a nice return.
The stock price of BKDT dropped by -26.94% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
BKDT's Dividend Yield is rather good when compared to the industry average which is at 2.85. BKDT pays more dividend than 98.15% of the companies in the same industry.
BKDT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.03% |
5.2 History
BKDT has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y11.29%
EPS Next 3Y9.21%
BROOKDALE SENIOR LIVING - BKD 7 11/15/25
NYSE:BKDT (1/29/2025, 8:06:45 PM)
68.84
-0.12 (-0.17%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners107.63%
Inst Owner ChangeN/A
Ins Owners3.14%
Ins Owner ChangeN/A
Market Cap13.71B
Analysts73.33
Price Target105.12 (52.7%)
Short Float %0%
Short Ratio0
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.03% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-18.94%
Min EPS beat(2)-25.67%
Max EPS beat(2)-12.21%
EPS beat(4)1
Avg EPS beat(4)-23.91%
Min EPS beat(4)-84.2%
Max EPS beat(4)26.45%
EPS beat(8)4
Avg EPS beat(8)12.01%
EPS beat(12)5
Avg EPS beat(12)3.43%
EPS beat(16)7
Avg EPS beat(16)19.75%
Revenue beat(2)0
Avg Revenue beat(2)-1.1%
Min Revenue beat(2)-1.2%
Max Revenue beat(2)-1%
Revenue beat(4)0
Avg Revenue beat(4)-1.03%
Min Revenue beat(4)-1.2%
Max Revenue beat(4)-0.88%
Revenue beat(8)0
Avg Revenue beat(8)-0.78%
Revenue beat(12)0
Avg Revenue beat(12)-0.7%
Revenue beat(16)1
Avg Revenue beat(16)-1.18%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-47.62%
EPS NY rev (1m)0%
EPS NY rev (3m)-18.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.93%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.16%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 4.43 | ||
| P/FCF | N/A | ||
| P/OCF | 91.24 | ||
| P/B | 46.82 | ||
| P/tB | 51.64 | ||
| EV/EBITDA | 42.37 |
EPS(TTM)-0.92
EYN/A
EPS(NY)-0.64
Fwd EYN/A
FCF(TTM)-0.3
FCFYN/A
OCF(TTM)0.75
OCFY1.1%
SpS15.56
BVpS1.47
TBVpS1.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.52% | ||
| ROE | -71.42% | ||
| ROCE | 1.08% | ||
| ROIC | 0.86% | ||
| ROICexc | 0.9% | ||
| ROICexgc | 0.91% | ||
| OM | 1.87% | ||
| PM (TTM) | N/A | ||
| GM | 25.68% | ||
| FCFM | N/A |
ROA(3y)-2.99%
ROA(5y)-2.3%
ROE(3y)-33.99%
ROE(5y)-26.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y54.5%
ROICexcg growth 5Y-15.52%
ROICexc growth 3Y55.62%
ROICexc growth 5Y-14.95%
OM growth 3Y53.94%
OM growth 5Y-9.99%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y0.99%
F-Score5
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 14.54 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 10.17 | ||
| Cap/Depr | 58.1% | ||
| Cap/Sales | 6.76% | ||
| Interest Coverage | 0.24 | ||
| Cash Conversion | 35.92% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.81 | ||
| Quick Ratio | 0.81 | ||
| Altman-Z | 1.06 |
F-Score5
WACC8.16%
ROIC/WACC0.1
Cap/Depr(3y)58.42%
Cap/Depr(5y)86.44%
Cap/Sales(3y)7.11%
Cap/Sales(5y)9.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-61.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y11.63%
EPS Next 2Y11.29%
EPS Next 3Y9.21%
EPS Next 5YN/A
Revenue 1Y (TTM)4.63%
Revenue growth 3Y-5.2%
Revenue growth 5Y-7.82%
Sales Q2Q%3.55%
Revenue Next Year3.68%
Revenue Next 2Y3.96%
Revenue Next 3Y0.41%
Revenue Next 5YN/A
EBIT growth 1Y391.65%
EBIT growth 3Y45.93%
EBIT growth 5Y-17.03%
EBIT Next Year1851.8%
EBIT Next 3Y186.67%
EBIT Next 5YN/A
FCF growth 1Y75.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y607.78%
OCF growth 3Y-7.46%
OCF growth 5Y-4.4%